Sep 29

Scientific

SS 17 - Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

Room 152

10:45am - 12:00pm PT

Hematologic Malignancies

MODERATOR(S)

Penny Fang, MD, MBA - MD Anderson Cancer Center

Mohammad Khan, MD, PhD - Emory University

Credits

AMA PRA Category 1 Credits:	1.00
CAMPEP Credits:	1.25
MDCB Credits:	1.25

Presentations

10:45am - 12:00pm PT

Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

Speaker: Mohammad Khan, MD, PhD - Emory University, Atlanta
10:45am - 10:55am PT

Improved Progression-Free and Overall Survival with Radiotherapy Consolidation Post-Autologous Stem Cell Transplant in Patients with Relapsed/Refractory Aggressive Lymphoma with Pre-Transplant Partial Metabolic Response on FDG-PET

Speaker: Chathuri Abeyakoon, MBBS - Princess Margaret Cancer Center, University Health Network, Toronto
10:45am - 12:00pm PT

Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

Speaker: Penny Fang, MD, MBA - MD Anderson Cancer Center, Houston
10:55am - 11:05am PT

TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma

Speaker: Alok Deshane, MD - MSKCC, New York
11:05am - 11:15am PT

Treatment Kinetics and Local Response during and after Bridging Radiotherapy prior to CAR-T Cell Therapy for Lymphomas

Speaker: Dasha Klebaner, MD, MPH - Stanford University Cancer Center, Palo Alto
11:15am - 11:25am PT

CNS Bridging Radiotherapy prior to CAR T-Cell Therapy for B-Cell Lymphomas

Speaker: Pule Wang, MD - City of Hope Cancer Center, Duarte
11:25am - 11:35am PT

Mechanisms of Acquired Radioresistance in Diffuse Large B-Cell Lymphoma

Speaker: Fabian Troschel, MD - Muenster University, Muenster
11:35am - 11:45am PT

Discussant

Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham